7 9 9 1 4

论文已发表


注册即可获取德孚的最新动态



IF 收录期刊





更多详情 >>



作者优惠计划

Favored Author Program


很高兴为我们的作者提供一种切实的方法以支持开放获取,并鼓励教师和研究人员通过开放获取模式,尽可能广泛地推广他们的作品。


作者优惠计划的成员将获得:


文章发表费(APC) 10% 的折扣


这 10% 的折扣从您加入 “作者优惠计划” 之时开始,并将适用于之后提交的所有论文



*若要加入“作者优惠计划”,您需要已经在德孚医药出版社发表过论文,或为我们进行过同行评审。作者必须在提交论文之前注册该优惠计划,折扣不能追溯应用于已提交的论文




更多详情 >>



已发表论文

基因变异和脑膜瘤风险增加: 一项更新的综合分析

 

Authors Han X, Wang W, Wang L, Wang X, Li G

Received 13 December 2016

Accepted for publication 22 February 2017

Published 28 March 2017 Volume 2017:10 Pages 1875—1888

DOI https://doi.org/10.2147/OTT.S130147

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr XuYu Yang

Purpose: Various genetic variants have been reported to be linked to an increased risk of meningioma. However, no confirmed conclusion has been obtained. The purpose of the study was to investigate potential meningioma-associated gene polymorphisms, based on published evidence.
Materials and methods: An updated meta-analysis was performed in September 2016. After electronic database searching and study screening, we selected eligible case-control studies and extracted data for meta-analysis, using Mantel–Haenszel statistics. -values, pooled odds ratios (ORs), and 95% confidence intervals were calculated.
Results: 
We finally selected eight genes with ten polymorphisms: MLLT10  rs12770228, CASP8  rs1045485, XRCC1  rs1799782, rs25487, MTHFR  rs1801133, rs1801131, MTRR  rs1801394, MTR  rs1805087, GSTM1  null/present, and GSTT1  null/present. Results of meta-analyses showed that there was increased meningioma risk in case groups under all models of MLLT10  rs12770228 (all OR >1, <0.001), compared with control groups. Similar results were observed under the allele, homozygote, dominant, and recessive models of MTRR  rs1801394 (all OR >1, <0.05), and the heterozygote and dominant models of MTHFR  rs1801131 in the Caucasian population (all OR >1, <0.05). However, no significantly increased meningioma risks were observed for CASP8  rs1045485, XRCC1  rs25487, rs1799782, MTHFR  rs1801133, MTR  rs1805087, or GSTM1/GSTT1  null mutations.

Conclusion: Our updated meta-analysis provided statistical evidence for the role of MLLT10  rs12770228, MTRR  rs1801394, and MTHFR  rs1801131 in increased susceptibility to meningioma.
Keywords: meningioma, meta-analysis, gene, SNP